These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 32879878)

  • 1. Relation of Fibrinogen-to-Albumin Ratio to Severity of Coronary Artery Disease and Long-Term Prognosis in Patients with Non-ST Elevation Acute Coronary Syndrome.
    Li M; Tang C; Luo E; Qin Y; Wang D; Yan G
    Biomed Res Int; 2020; 2020():1860268. PubMed ID: 32879878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the LDL-C/HDL-C ratio as a predictor of one year clinical outcomes in patients with acute coronary syndromes after percutaneous coronary intervention and drug-eluting stent implantation.
    Zhong Z; Hou J; Zhang Q; Zhong W; Li B; Li C; Liu Z; Yang M; Zhao P
    Lipids Health Dis; 2019 Feb; 18(1):40. PubMed ID: 30711009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of cigarette smoking on extent of coronary artery disease and prognosis of patients with non-ST-segment elevation acute coronary syndromes: an analysis from the ACUITY Trial (Acute Catheterization and Urgent Intervention Triage Strategy).
    Robertson JO; Ebrahimi R; Lansky AJ; Mehran R; Stone GW; Lincoff AM
    JACC Cardiovasc Interv; 2014 Apr; 7(4):372-9. PubMed ID: 24630881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between fibrinogen-to-albumin ratio and the presence and severity of coronary artery disease in patients with acute coronary syndrome.
    Duan Z; Luo C; Fu B; Han D
    BMC Cardiovasc Disord; 2021 Dec; 21(1):588. PubMed ID: 34876026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between fibrinogen to albumin ratio and severity of coronary artery disease in patients with STEMI.
    Karahan O; Acet H; Ertaş F; Tezcan O; Çalişkan A; Demir M; Kaya AF; Demirtaş S; Çevik MU; Yavuz C
    Am J Emerg Med; 2016 Jun; 34(6):1037-42. PubMed ID: 27017405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multivessel vs single-vessel revascularization in patients with non-ST-segment elevation acute coronary syndrome and multivessel disease in the drug-eluting stent era.
    Lee HJ; Song YB; Hahn JY; Kim SM; Yang JH; Choi JH; Choi SH; Choi JH; Lee SH; Gwon HC
    Clin Cardiol; 2011 Mar; 34(3):160-5. PubMed ID: 21400543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CHA2DS2-VASc-HS score in non-ST elevation acute coronary syndrome patients: assessment of coronary artery disease severity and complexity and comparison to other scoring systems in the prediction of in-hospital major adverse cardiovascular events.
    Taşolar H; Çetin M; Ballı M; Bayramoğlu A; Otlu YÖ; Türkmen S; Aktürk E
    Anatol J Cardiol; 2016 Oct; 16(10):742-748. PubMed ID: 27025198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive troponin in diabetic ketoacidosis without evident acute coronary syndrome predicts adverse cardiac events.
    Al-Mallah M; Zuberi O; Arida M; Kim HE
    Clin Cardiol; 2008 Feb; 31(2):67-71. PubMed ID: 18257021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary artery disease severity and risk stratification of patients with non ST-elevation acute coronary syndrome using CHA
    Abdelmegid MAF; Hanna MEF; Demitry SR; Abdelhafez MAH
    BMC Cardiovasc Disord; 2024 May; 24(1):263. PubMed ID: 38773382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial.
    Serruys PW; Farooq V; Kalesan B; de Vries T; Buszman P; Linke A; Ischinger T; Klauss V; Eberli F; Wijns W; Morice MC; Di Mario C; Corti R; Antoni D; Sohn HY; Eerdmans P; Rademaker-Havinga T; van Es GA; Meier B; Jüni P; Windecker S
    JACC Cardiovasc Interv; 2013 Aug; 6(8):777-89. PubMed ID: 23968698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcomes of patients with multivessel coronary artery disease presenting non-ST-segment elevation acute coronary syndromes.
    Desperak P; Hawranek M; Gąsior P; Desperak A; Lekston A; Gąsior M
    Cardiol J; 2019; 26(2):157-168. PubMed ID: 28980282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of preprocedural troponin-I in patients with non-ST elevation acute coronary syndromes undergoing percutaneous coronary intervention.
    Napan S; Kashinath RC; Kadri S; Orig MN; Khadra S
    Coron Artery Dis; 2010 Aug; 21(5):261-5. PubMed ID: 20555264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anatomic- and clinical-based NERS (new risk stratification) score II to predict clinical outcomes after stenting unprotected left main coronary artery disease: results from a multicenter, prospective, registry study.
    Chen SL; Han YL; Zhang YJ; Ye F; Liu HW; Zhang JJ; Xu B; Jiang TM; Zhou YJ; Lv SZ
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1233-41. PubMed ID: 24239199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gamma-glutamyltransferase in acute coronary syndrome patients without ST elevation and its association with stenotic lesion and cardiac events.
    Dogan A; Icli A; Aksoy F; Varol E; Erdogan D; Ozaydin M; Kocyigit S
    Coron Artery Dis; 2012 Jan; 23(1):39-44. PubMed ID: 22107801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of fibrinogen-to-albumin ratio combined with coronary calcification score in patients with suspected coronary artery disease.
    Tian XX; Luo JY; Liu F; Qiu YJ; Luo F; Zeng L; Zhang ZR; Yang YN; Li XM
    BMC Cardiovasc Disord; 2023 Apr; 23(1):181. PubMed ID: 37016312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dynamic changes of complement level in patients with acute coronary syndrome and its relationships with myocardial injury].
    Shao A; Qi X; Li Q; Jia W; Wei L; Hou W; Qi Y; Liu Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Jun; 29(6):515-519. PubMed ID: 28625240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of GRACE and SYNTAX scores for predicting the prognosis of patients with non-ST elevation acute coronary syndrome.
    Wang XF; Zhao M; Liu F; Sun GR
    World J Clin Cases; 2021 Nov; 9(33):10143-10150. PubMed ID: 34904084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of drug-eluting balloons alone or in combination with drug-eluting stents in the treatment of de novo diffuse coronary disease.
    Costopoulos C; Latib A; Naganuma T; Sticchi A; Figini F; Basavarajaiah S; Carlino M; Chieffo A; Montorfano M; Naim C; Kawaguchi M; Giannini F; Colombo A
    JACC Cardiovasc Interv; 2013 Nov; 6(11):1153-9. PubMed ID: 24262615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous coronary intervention for acute coronary syndrome due to graft failure: use of bare-metal and drug-eluting stents and subsequent long-term clinical outcome.
    Harskamp RE; Kuijt WJ; Damman P; Beijk MA; Grundeken MJ; Woudstra P; Tijssen JG; de Winter RJ
    Catheter Cardiovasc Interv; 2014 Feb; 83(2):203-9. PubMed ID: 22508617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial.
    Jeger RV; Farah A; Ohlow MA; Mangner N; Möbius-Winkler S; Weilenmann D; Wöhrle J; Stachel G; Markovic S; Leibundgut G; Rickenbacher P; Osswald S; Cattaneo M; Gilgen N; Kaiser C; Scheller B;
    Lancet; 2020 Nov; 396(10261):1504-1510. PubMed ID: 33091360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.